SBC
SBC Medical Group Holdings Incorporated
Price Chart
Latest Quote
$3.01
+0.01 (+0.33%)
Current Price
| Previous Close | $3.00 |
| Open | $3.05 |
| Day High | $3.07 |
| Day Low | $3.01 |
| Volume | 44,751 |
Stock Information
| Shares Outstanding | 102.58M |
| Total Debt | $51.90M |
| Cash Equivalents | $167.62M |
| Revenue | $169.34M |
| Net Income | $40.79M |
| Sector | Industrials |
| Industry | Consulting Services |
| Market Cap | $314.91M |
| P/E Ratio | 7.67 |
| EPS (TTM) | $0.40 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $215.06M |
| Sales | $169.34M |
| Income | $40.79M |
| Book/sh | $2.49 |
| Cash/sh | $1.63 |
| Employees | 863 |
Financial Ratios
| Quick Ratio | 3.62 |
| Current Ratio | 3.82 |
| Debt/Eq | 19.20 |
| EPS Growth TTM | -47.40% |
Returns & Margins
| ROA | 11.34% |
| ROE | 16.46% |
| Gross Margin | 70.80% |
| Operating Margin | 41.15% |
| Profit Margin | 24.09% |
Ownership
| Insider Ownership | 81.75% |
| Institutional Ownership | 1.43% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 6.33 |
| P/S | 1.86 |
| P/B | 1.23 |
Analyst Data
| Recommendation | none |
| Target Price | $8.50 |
Technical Indicators
| SMA20 | $3.06 |
| SMA50 | $3.33 |
| SMA200 | $3.88 |
| RSI | 39.39 |
| ATR | 0.1332 |
| Shares Float | 12.03M |
| Short Float | 2.08% |
| Short Ratio | 2.71 |
| Volatility | 0.59 |
| Rel Volume | 0.71 |
Performance History
| Week | +2.68% |
| Month | +6.23% |
| Quarter | -15.43% |
| 6 Months | -25.12% |
| YTD | -29.10% |
| Year | -32.23% |
| 3 Years | -70.11% |
| 10 Years | -69.18% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $3.07 | 78,200 |
| 2026-06-17 | $3.00 | 98,100 |
| 2026-06-16 | $2.99 | 77,500 |
| 2026-06-15 | $2.91 | 62,900 |
| 2026-06-12 | $2.87 | 86,400 |
| 2026-06-11 | $2.99 | 87,900 |
| 2026-06-10 | $3.02 | 57,000 |
| 2026-06-09 | $2.99 | 62,200 |
| 2026-06-08 | $2.96 | 73,100 |
| 2026-06-05 | $3.01 | 111,000 |
| 2026-06-04 | $3.06 | 65,500 |
| 2026-06-03 | $3.07 | 98,300 |
| 2026-06-02 | $3.20 | 78,400 |
| 2026-06-01 | $3.21 | 367,800 |
| 2026-05-29 | $3.21 | 260,900 |
| 2026-05-28 | $3.19 | 180,700 |
| 2026-05-27 | $3.10 | 78,700 |
| 2026-05-26 | $3.12 | 117,000 |
| 2026-05-22 | $3.07 | 70,600 |
| 2026-05-21 | $3.10 | 86,000 |
| 2026-05-20 | $3.23 | 181,000 |
| 2026-05-19 | $2.89 | 176,600 |
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
đ° Latest News
Results: SBC Medical Group Holdings Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Simply Wall St. âĸ 2026-05-18T12:58:50Z
SBC Medical Group Holdings Inc (SBC) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
GuruFocus.com âĸ 2026-05-14T23:01:15ZSBC Medical Group Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-14T19:05:30Z
SBC Medical (SBC): A Miss on Paper â But Thereâs More Behind It
Insider Monkey âĸ 2026-04-08T20:15:45Z
SBC Medical Group Holdings Inc (SBC) Q4 2025 Earnings Call Highlights: Strategic Expansion and ...
GuruFocus.com âĸ 2026-04-03T01:00:51Z3 Promising Penny Stocks With Market Caps Up To $200M
Simply Wall St. âĸ 2026-03-31T12:05:18Z
SBC Medical Group Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-27T14:07:58Z
Capital Allocation Trends At SBC Medical Group Holdings (NASDAQ:SBC) Aren't Ideal
Simply Wall St. âĸ 2025-12-15T11:15:22Z
Japanese Bitcoin treasury stocks soar after Metaplanet raises $130m loan to buy crypto
DLNews âĸ 2025-11-27T16:56:47Z
SBC Medical Group Holdings Inc (SBC) Q3 2025 Earnings Call Highlights: Expansion and Strategic ...
GuruFocus.com âĸ 2025-11-18T05:01:04Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $46,323,767 | $49,365,035 | $56,238,385 | $59,327,724 |
| Cost Of Revenue | $46,323,767 | $49,365,035 | $56,238,385 | $59,327,724 |
| Total Revenue | $173,607,489 | $205,415,542 | $193,542,423 | $174,160,618 |
| Operating Revenue | $173,607,489 | $205,415,542 | $193,542,423 | $174,160,618 |
| Expenses | ||||
| Interest Expense | $160,583 | $28,300 | $45,292 | $31,441 |
| Total Expenses | $106,121,091 | $120,052,867 | $122,473,327 | $152,812,304 |
| Other Income Expense | $14,541,500 | $-11,898,501 | $2,468,783 | $1,887,512 |
| Other Non Operating Income Expenses | $3,792,573 | $-1,548,856 | $2,877,813 | $3,118,287 |
| Net Non Operating Interest Income Expense | $37,732 | $-8,357 | $41,456 | $440,941 |
| Interest Expense Non Operating | $160,583 | $28,300 | $45,292 | $31,441 |
| Operating Expense | $59,797,324 | $70,687,832 | $66,234,942 | $93,484,580 |
| General And Administrative Expense | $59,797,324 | $70,687,832 | $66,234,942 | $93,484,580 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $50,985,613 | $46,614,275 | $39,370,036 | $6,315,002 |
| Net Interest Income | $37,732 | $-8,357 | $41,456 | $440,941 |
| Interest Income | $198,315 | $19,943 | $86,748 | $472,382 |
| Normalized Income | $44,299,780 | $53,192,509 | $39,693,170 | $7,287,314 |
| Net Income From Continuing And Discontinued Operation | $50,985,613 | $46,614,275 | $39,370,036 | $6,315,002 |
| Total Operating Income As Reported | $67,486,398 | $70,303,710 | $70,660,066 | $20,117,539 |
| Net Income Common Stockholders | $50,985,613 | $46,614,275 | $39,370,036 | $6,315,002 |
| Net Income | $50,985,613 | $46,614,275 | $39,370,036 | $6,315,002 |
| Net Income Including Noncontrolling Interests | $51,045,023 | $46,689,892 | $38,560,606 | $5,552,418 |
| Net Income Continuous Operations | $51,045,023 | $46,689,892 | $38,560,606 | $5,552,418 |
| Pretax Income | $82,065,630 | $73,455,817 | $73,579,335 | $23,676,767 |
| Special Income Charges | $8,746,138 | $-11,245,356 | $-409,030 | $-1,230,775 |
| Interest Income Non Operating | $198,315 | $19,943 | $86,748 | $472,382 |
| Operating Income | $67,486,398 | $85,362,675 | $71,069,096 | $21,348,314 |
| Gross Profit | $127,283,722 | $156,050,507 | $137,304,038 | $114,832,894 |
| Per Share | ||||
| Diluted EPS | $0.50 | $0.48 | $0.39 | $0.06 |
| Basic EPS | $0.50 | $0.48 | $0.39 | $0.06 |
| Other | ||||
| Tax Effect Of Unusual Items | $4,063,094 | $-3,771,411 | $-85,896 | $-258,463 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $74,161,586 | $87,633,139 | $86,280,599 | $30,871,036 |
| Total Unusual Items | $10,748,927 | $-10,349,645 | $-409,030 | $-1,230,775 |
| Total Unusual Items Excluding Goodwill | $10,748,927 | $-10,349,645 | $-409,030 | $-1,230,775 |
| Reconciled Depreciation | $2,684,300 | $3,799,377 | $12,246,942 | $5,932,053 |
| EBITDA (Bullshit earnings) | $84,910,513 | $77,283,494 | $85,871,569 | $29,640,261 |
| EBIT | $82,226,213 | $73,484,117 | $73,624,627 | $23,708,208 |
| Diluted Average Shares | $102,997,967 | $96,561,041 | $100,743,253 | $100,743,253 |
| Basic Average Shares | $102,997,967 | $96,561,041 | $100,743,253 | $100,743,253 |
| Diluted NI Availto Com Stockholders | $50,985,613 | $46,614,275 | $39,370,036 | $6,315,002 |
| Minority Interests | $-59,410 | $-75,617 | $809,430 | $762,584 |
| Tax Provision | $31,020,607 | $26,765,925 | $35,018,729 | $18,124,349 |
| Gain On Sale Of Business | $0 | $3,813,609 | $0 | - |
| Other Special Charges | $-8,746,138 | - | $409,030 | $979,603 |
| Impairment Of Capital Assets | $0 | $15,058,965 | $0 | $251,172 |
| Gain On Sale Of Security | $2,002,789 | $895,711 | - | - |
| Selling General And Administration | $59,797,324 | $70,687,832 | $66,234,942 | $93,484,580 |
| Other Gand A | $59,797,324 | $57,665,140 | $66,234,942 | $70,654,294 |
| Salaries And Wages | $0 | $13,022,692 | $0 | $22,830,286 |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $185,107,247 | $188,905,321 | $118,829,110 | $94,114,688 |
| Total Assets | $380,447,946 | $266,083,154 | $258,805,271 | $225,482,399 |
| Total Non Current Assets | $149,223,831 | $81,632,134 | $92,899,345 | $112,533,757 |
| Other Non Current Assets | $3,645,869 | $12,052,603 | $11,745,305 | $14,893,874 |
| Non Current Prepaid Assets | $3,497,767 | $4,667,656 | $7,148,875 | $52,414,326 |
| Non Current Deferred Assets | $4,014,294 | $9,798,071 | $0 | $5,271,633 |
| Non Current Deferred Taxes Assets | $4,014,294 | $9,798,071 | $0 | $5,271,633 |
| Non Current Note Receivables | $5,338,303 | $5,602,546 | $7,091,666 | $1,115,954 |
| Non Current Accounts Receivable | $13,746,513 | $8,397,582 | $3,420,489 | $5,277,128 |
| Goodwill And Other Intangible Assets | $63,174,949 | $6,203,836 | $23,330,067 | $11,135,427 |
| Other Intangible Assets | $47,742,888 | $1,590,052 | $19,739,276 | $7,269,571 |
| Current Assets | $231,224,115 | $184,451,020 | $165,905,926 | $112,948,642 |
| Other Current Assets | $127,179 | $25,536 | $162,121 | $37,228 |
| Prepaid Assets | $11,111,347 | $9,693,043 | $6,497,608 | $14,270,179 |
| Inventory | $2,792,617 | $1,494,891 | $3,090,923 | $1,350,057 |
| Receivables | $53,099,941 | $48,193,458 | $53,132,342 | $43,646,584 |
| Other Receivables | $13,318,681 | $7,550,808 | $8,533,840 | $22,800,209 |
| Taxes Receivable | $1,175,510 | $0 | $0 | $7,752,614 |
| Loans Receivable | $8,705,999 | $10,382,537 | $8,484,753 | $0 |
| Accounts Receivable | $29,899,751 | $30,260,113 | $35,113,749 | $13,093,761 |
| Cash Cash Equivalents And Short Term Investments | $164,093,031 | $125,044,092 | $103,022,932 | $53,644,594 |
| Cash And Cash Equivalents | $163,773,838 | $125,044,092 | $103,022,932 | $51,737,994 |
| Notes Receivable | - | $0 | $1,000,000 | $0 |
| Debt | ||||
| Total Debt | $51,636,174 | $12,214,143 | $22,866,489 | $16,129,606 |
| Long Term Debt And Capital Lease Obligation | $37,987,222 | $7,749,542 | $15,455,257 | $7,889,796 |
| Long Term Debt | $33,734,438 | $6,508,016 | $13,010,941 | $5,528,344 |
| Current Debt And Capital Lease Obligation | $13,648,952 | $4,464,601 | $7,411,232 | $8,239,810 |
| Current Debt | $9,099,046 | $123,079 | $3,525,420 | $4,759,939 |
| Other Current Borrowings | $9,099,046 | $123,079 | $3,525,420 | $4,759,939 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $117,143,240 | $71,060,996 | $114,995,022 | $117,632,316 |
| Total Non Current Liabilities Net Minority Interest | $56,022,237 | $9,869,106 | $22,543,752 | $16,379,831 |
| Other Non Current Liabilities | $1,660,183 | $1,193,541 | $1,074,930 | $1,152,168 |
| Non Current Deferred Liabilities | $16,374,832 | $926,023 | $6,013,565 | $7,337,867 |
| Non Current Deferred Taxes Liabilities | $16,374,832 | $926,023 | $6,013,565 | $7,337,867 |
| Current Liabilities | $61,121,003 | $61,191,890 | $92,451,270 | $101,252,485 |
| Other Current Liabilities | $5,430,691 | $242,989 | $832,523 | $2,298,136 |
| Current Deferred Liabilities | $6,772,983 | $12,560,431 | $25,132,632 | $30,443,453 |
| Payables And Accrued Expenses | $35,268,377 | $43,923,869 | $59,074,883 | $37,370,323 |
| Payables | $35,268,377 | $43,923,869 | $59,074,883 | $37,370,323 |
| Other Payable | $3,892,930 | $3,173,679 | $6,264,711 | $7,428,384 |
| Total Tax Payable | $11,042,927 | $23,392,377 | $22,694,705 | $11,543,167 |
| Income Tax Payable | $8,821,853 | $18,705,851 | $8,782,930 | $3,427,089 |
| Accounts Payable | $17,639,847 | $14,534,223 | $26,531,944 | $15,321,562 |
| Equity | ||||
| Common Stock Equity | $248,282,196 | $195,109,157 | $142,159,177 | $105,250,115 |
| Total Equity Gross Minority Interest | $263,304,706 | $195,022,158 | $143,810,249 | $107,850,083 |
| Stockholders Equity | $248,282,196 | $195,109,157 | $142,159,177 | $105,250,115 |
| Gains Losses Not Affecting Retained Earnings | $-57,294,239 | $-54,178,075 | $-37,578,255 | $-24,853,275 |
| Other Equity Adjustments | $-57,294,239 | $-54,178,075 | $-37,578,255 | $-24,853,275 |
| Retained Earnings | $240,448,620 | $189,463,007 | $142,848,732 | $103,478,696 |
| Long Term Equity Investment | $20,312,642 | $0 | - | - |
| Investments In Other Ventures Under Equity Method | $20,312,642 | $0 | - | - |
| Other | ||||
| Treasury Shares Number | $1,304,308 | $270,000 | - | - |
| Ordinary Shares Number | $102,576,943 | $102,750,816 | $100,743,253 | $100,743,253 |
| Share Issued | $103,881,251 | $103,020,816 | $100,743,253 | $100,743,253 |
| Tangible Book Value | $185,107,247 | $188,905,321 | $118,829,110 | $94,114,688 |
| Invested Capital | $291,115,680 | $201,740,252 | $158,695,538 | $115,538,398 |
| Working Capital | $170,103,112 | $123,259,130 | $73,454,656 | $11,696,157 |
| Capital Lease Obligations | $8,802,690 | $5,583,048 | $6,330,128 | $5,841,323 |
| Total Capitalization | $282,016,634 | $201,617,173 | $155,170,118 | $110,778,459 |
| Minority Interest | $15,022,510 | $-86,999 | $1,651,072 | $2,599,968 |
| Treasury Stock | $7,749,997 | $2,700,000 | $0 | - |
| Additional Paid In Capital | $72,867,424 | $62,513,923 | $36,879,281 | $26,624,694 |
| Capital Stock | $10,388 | $10,302 | $9,419 | $0 |
| Common Stock | $10,388 | $10,302 | $9,419 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $4,252,784 | $1,241,526 | $2,444,316 | $2,361,452 |
| Current Deferred Revenue | $6,772,983 | $12,560,431 | $25,132,632 | $30,443,453 |
| Current Capital Lease Obligation | $4,549,906 | $4,341,522 | $3,885,812 | $3,479,871 |
| Dueto Related Parties Current | $2,692,673 | $2,823,590 | $3,583,523 | $3,077,210 |
| Investments And Advances | $39,449,301 | $20,870,882 | $20,660,989 | $916,030 |
| Other Investments | $19,136,659 | $20,870,882 | $20,660,989 | - |
| Goodwill | $15,432,061 | $4,613,784 | $3,590,791 | $3,865,856 |
| Net PPE | $16,356,835 | $14,038,958 | $19,501,954 | $21,509,385 |
| Accumulated Depreciation | $-9,139,257 | $-11,243,560 | $-10,631,305 | $-35,715,894 |
| Gross PPE | $25,496,092 | $25,282,518 | $30,133,259 | $57,225,279 |
| Construction In Progress | $2,041,608 | $0 | $591,306 | $398,706 |
| Other Properties | $8,817,443 | $5,267,056 | $5,919,937 | $5,549,037 |
| Machinery Furniture Equipment | $10,349,453 | $12,633,906 | $13,410,225 | $35,175,919 |
| Buildings And Improvements | $4,287,588 | $5,373,424 | $8,412,348 | $12,366,461 |
| Land And Improvements | $0 | $2,008,132 | $1,799,443 | $3,735,156 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $319,193 | $0 | $0 | $1,906,600 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $0 | $22,900,763 |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $21,964,463 | $17,174,550 | $39,462,374 | $-24,992,739 |
| Operating Activities | ||||
| Operating Cash Flow | $24,668,496 | $20,582,933 | $50,670,322 | $-47,369 |
| Cash Flow From Continuing Operating Activities | $24,668,496 | $20,582,933 | $50,670,322 | $-47,369 |
| Operating Gains Losses | $-3,994,528 | $-3,301,662 | $-472,696 | $-1,902,524 |
| Investing Activities | ||||
| Capital Expenditure | $-2,704,033 | $-3,408,383 | $-11,207,948 | $-24,945,370 |
| Investing Cash Flow | $-20,971,552 | $-10,102,410 | $1,793,631 | $-32,650,392 |
| Cash Flow From Continuing Investing Activities | $-20,971,552 | $-10,102,410 | $1,793,631 | $-32,650,392 |
| Net Other Investing Changes | $17,878,533 | $-1,294,106 | $2,239,260 | $-809,116 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-4,999,997 | $0 | - | - |
| Financing Cash Flow | $38,292,183 | $22,965,400 | $6,135,368 | $-7,977,403 |
| Cash Flow From Continuing Financing Activities | $38,292,183 | $22,965,400 | $6,135,368 | $-7,977,403 |
| Net Other Financing Charges | $10,207,670 | $10,968,003 | $2,556,194 | $-2,893,686 |
| Net Common Stock Issuance | $-4,999,997 | $0 | $10 | $0 |
| Issuance Of Capital Stock | - | $0 | $10 | $0 |
| Common Stock Issuance | - | $0 | $10 | $0 |
| Other | ||||
| Repayment Of Debt | $-1,684,436 | $-119,017 | $-8,730,942 | $-5,207,915 |
| Issuance Of Debt | $34,768,946 | $12,085,040 | $12,310,106 | $124,198 |
| Interest Paid Supplemental Data | $160,583 | $28,300 | $45,292 | $31,441 |
| Income Tax Paid Supplemental Data | $37,190,188 | $30,239,002 | $17,842,407 | $30,824,511 |
| End Cash Position | $163,773,838 | $125,044,092 | $103,022,932 | $51,737,994 |
| Beginning Cash Position | $125,044,092 | $103,022,932 | $51,737,994 | $104,503,554 |
| Effect Of Exchange Rate Changes | $-3,259,381 | $-11,424,763 | $-7,314,383 | $-12,090,396 |
| Changes In Cash | $41,989,127 | $33,445,923 | $58,599,321 | $-40,675,164 |
| Proceeds From Stock Option Exercised | $0 | $31,374 | $0 | - |
| Common Stock Payments | $-4,999,997 | $0 | - | - |
| Net Issuance Payments Of Debt | $33,084,510 | $11,966,023 | $3,579,164 | $-5,083,717 |
| Net Long Term Debt Issuance | $33,084,510 | $11,966,023 | $3,579,164 | $-5,083,717 |
| Long Term Debt Payments | $-1,684,436 | $-119,017 | $-8,730,942 | $-5,207,915 |
| Long Term Debt Issuance | $34,768,946 | $12,085,040 | $12,310,106 | $124,198 |
| Net Investment Purchase And Sale | $-620,492 | $-331,496 | $1,993,761 | $-2,645,729 |
| Sale Of Investment | $457,828 | $0 | $4,127,261 | $0 |
| Purchase Of Investment | $-1,078,320 | $-331,496 | $-2,133,500 | $-2,645,729 |
| Net Business Purchase And Sale | $-43,004,343 | $-5,068,425 | $722,551 | $-6,486,251 |
| Purchase Of Business | $-43,004,343 | $-5,068,425 | $0 | $-6,486,251 |
| Net PPE Purchase And Sale | $4,774,750 | $-3,408,383 | $-1,478,911 | $-22,709,296 |
| Sale Of PPE | $7,478,783 | $0 | $8,046,007 | $2,236,074 |
| Purchase Of PPE | $-2,704,033 | $-3,408,383 | $-9,524,918 | $-24,945,370 |
| Change In Working Capital | $-26,534,822 | $-46,884,277 | $-7,650,529 | $-10,587,536 |
| Change In Other Working Capital | $-6,089,055 | $-10,620,271 | $-3,803,141 | $2,476,349 |
| Change In Other Current Liabilities | $-4,916,488 | $-3,910,372 | $-3,153,860 | $-3,497,737 |
| Change In Other Current Assets | $-195,846 | $-1,692,642 | $-1,328,682 | $-10,643,903 |
| Change In Payables And Accrued Expense | $-20,280,025 | $-44,530,897 | $7,906,752 | $17,133,606 |
| Change In Accrued Expense | $2,968,513 | $-12,096,825 | $-17,630,621 | $25,503,546 |
| Change In Payable | $-23,248,538 | $-32,434,072 | $25,537,373 | $-8,369,940 |
| Change In Account Payable | $2,666,495 | $-8,905,747 | $12,201,755 | $172,607 |
| Change In Tax Payable | $-11,662,531 | $11,228,429 | $13,359,434 | $-8,542,547 |
| Change In Income Tax Payable | $-11,662,531 | $11,228,429 | $13,359,434 | $-8,542,547 |
| Change In Prepaid Assets | $650,734 | $-357,935 | $563,528 | $-5,788,784 |
| Change In Inventory | $-170,174 | $1,124,805 | $-1,825,942 | $-666,638 |
| Change In Receivables | $4,466,032 | $13,103,035 | $-6,009,184 | $-9,600,429 |
| Changes In Account Receivables | $1,391,514 | $617,194 | $-22,998,370 | $-2,857,418 |
| Other Non Cash Items | $-4,047,407 | $3,870,198 | $3,297,824 | $3,401,437 |
| Stock Based Compensation | $0 | $13,022,692 | $0 | - |
| Unrealized Gain Loss On Investment Securities | $-247,514 | $2,617,435 | $0 | - |
| Provisionand Write Offof Assets | $302,949 | $-402,196 | $370,754 | $342,693 |
| Asset Impairment Charge | $133,513 | $15,588,561 | $204,026 | $1,114,487 |
| Deferred Tax | $5,326,982 | $-14,417,087 | $4,113,395 | $-3,900,397 |
| Deferred Income Tax | $5,326,982 | $-14,417,087 | $4,113,395 | $-3,900,397 |
| Depreciation Amortization Depletion | $2,684,300 | $3,799,377 | $12,246,942 | $5,932,053 |
| Depreciation And Amortization | $2,684,300 | $3,799,377 | $12,246,942 | $5,932,053 |
| Gain Loss On Sale Of PPE | $-3,179,200 | $511,947 | $-249,532 | $-1,902,524 |
| Gain Loss On Sale Of Business | $-815,328 | $-3,813,609 | $0 | - |
| Net Income From Continuing Operations | $51,045,023 | $46,689,892 | $38,560,606 | $5,552,418 |
| Net Intangibles Purchase And Sale | - | $0 | $-1,683,030 | $0 |
| Purchase Of Intangibles | - | $0 | $-1,683,030 | $0 |
| Sale Of Business | - | - | $722,551 | - |
| Gain Loss On Investment Securities | - | - | $-223,164 | - |
Fetched: 2026-06-16